Literature DB >> 7975255

An amino-proximal domain of the L protein binds to the P protein in the measles virus RNA polymerase complex.

S M Horikami1, S Smallwood, B Bankamp, S A Moyer.   

Abstract

The RNA polymerase of measles virus consists of two virus-encoded subunits, the L and P proteins with 2183 and 507 amino acids, respectively. When these proteins were coexpressed from plasmids in a mammalian expression system, a complex was formed as detected by the coimmunoprecipitation of the L protein with the P protein by anti-P antibodies. Pulse-chase experiments showed that complex formation increased the stability of the L protein. We have used the coimmunoprecipitation assay in conjunction with a series of C-terminal truncations of the L protein to map the region of the L protein which is involved in complex formation with the P protein. Mutant L proteins consisting of the N-terminal 1139, 916, 511, and 408 amino acids all bound to the P protein. An L protein truncation consisting of only the N-terminal 292 amino acids, which deleted part of the conserved domain I, however, did not bind the P protein. The data show that the N-terminal 408 amino acids of the L protein contain the P binding domain and suggest that domain I within this region of the L proteins of (-) strand RNA viruses may be important for RNA polymerase complex formation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7975255     DOI: 10.1006/viro.1994.1676

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  24 in total

1.  Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage.

Authors:  C L Parks; R A Lerch; P Walpita; H P Wang; M S Sidhu; S A Udem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Rinderpest virus RNA polymerase subunits: mapping of mutual interacting domains on the large protein L and phosphoprotein p.

Authors:  Anasuya Chattopadhyay; M S Shaila
Journal:  Virus Genes       Date:  2004-03       Impact factor: 2.332

3.  Oligomerization of Mumps Virus Phosphoprotein.

Authors:  Adrian Pickar; Andrew Elson; Yang Yang; Pei Xu; Ming Luo; Biao He
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

4.  Contributions of matrix and large protein genes of the measles virus edmonston strain to growth in cultured cells as revealed by recombinant viruses.

Authors:  Maino Tahara; Makoto Takeda; Yusuke Yanagi
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Mapping the interacting domains between the rabies virus polymerase and phosphoprotein.

Authors:  M Chenik; M Schnell; K K Conzelmann; D Blondel
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

6.  Structure of a paramyxovirus polymerase complex reveals a unique methyltransferase-CTD conformation.

Authors:  Ryan Abdella; Megha Aggarwal; Takashi Okura; Robert A Lamb; Yuan He
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-19       Impact factor: 11.205

Review 7.  Polymerases of paramyxoviruses and pneumoviruses.

Authors:  Rachel Fearns; Richard K Plemper
Journal:  Virus Res       Date:  2017-01-16       Impact factor: 3.303

8.  Measles virus nonstructural C protein modulates viral RNA polymerase activity by interacting with host protein SHCBP1.

Authors:  Minako Ito; Masaharu Iwasaki; Makoto Takeda; Takanori Nakamura; Yusuke Yanagi; Shinji Ohno
Journal:  J Virol       Date:  2013-06-26       Impact factor: 5.103

9.  Independent structural domains in paramyxovirus polymerase protein.

Authors:  Melanie Dochow; Stefanie A Krumm; James E Crowe; Martin L Moore; Richard K Plemper
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

10.  The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals.

Authors:  Martina Trunschke; Dominik Conrad; Sven Enterlein; Judith Olejnik; Kristina Brauburger; Elke Mühlberger
Journal:  Virology       Date:  2013-04-11       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.